Congress is out of session until Monday, November 9 for the midterm campaign. No new roll-call votes until then; the last were the House on Sep 16 and the Senate on Sep 30.

H.R. 5575 · 118th Congress · Health

Safe Medicine Act

Died in committee1.6k words Introduced Sep 19, 2023 · Latest action Dec 17, 2024

FollowRead the text
How far it has goneStopped at 2 of 6 · Died in committee
  1. IntroducedSep 19, 2023 Done
  2. CommitteeDied Jan 3, 2025 Stopped here
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

This bill addresses issues related to the manufacture of drugs, including essential medicines.

The Department of Health and Human Services, the Department of Defense, and the Department of Veterans Affairs must jointly develop and implement a strategy to increase the domestic production of essential medicines, medical countermeasures, and critical inputs.

If the Food and Drug Administration determines that a drug or active pharmaceutical ingredient is manufactured in a country that may be producing contaminated drugs or ingredients due to systemic manufacturing-related problems, the labeling for that drug or ingredient must have a boxed warning about the potential for contamination.

For government procurement purposes, the President's authority to waive certain purchasing requirements that discriminate against foreign products may not be used to waive any preferences for goods that are essential medicines, medical countermeasures, or critical inputs.

Congressional Research Service · summary of “Introduced in House” version · Sep 19, 2023

Who lobbies on it

No lobbying filing on file names H.R. 5575.

Organizations that named H.R. 5575 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field.

Actions

6 actions · newest first
  1. Dec 17, 2024Referred to the Subcommittee on Health.
  2. Dec 17, 2024Referred to the Subcommittee on Trade.
  3. Sep 28, 2023Referred to the Subcommittee on Health.
  4. Sep 22, 2023Referred to the Subcommittee on Health.
Show all 6 actionsShow fewer
  1. Sep 19, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committees on Armed Services, Veterans' Affairs, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  2. Sep 19, 2023Introduced in House